CAVE, M.C., HURT, R.T., FRAZIER, T.H., MATHESON, P.J., GARRISON, R.N., MCCLAIN, C.J
Supplementation approaches: For confirmed deficiency, treatment depends on severity and underlying cause
[3] These studies also suggest that DSIP could attenuate the excitatory actions of NMDA receptors, further contributing to its sleep-promoting properties
Europe accounted for 28% of global sales in 2025
Newer agents tend to produce greater glucose lowering and weight loss, but may also cause more gastrointestinal symptoms during dose escalation
By stimulating growth hormone release, these peptides may influence fat breakdown, providing insights into their potential use in metabolic research